Eli Lilly Acquires Gene Therapy Company Prevail Therapeutics for US$1.04 B

By Swati Sharan & Michelle Liu

Pharma Deals Review: Vol 2021 Issue 4 (Table of Contents)

Published: 16 Apr-2021

DOI: 10.3833/pdr.v2021.i4.2607     ISSN: 1756-7874

Section: Mergers & Acquisitions



Eli Lilly has agreed to acquire Prevail Therapeutics, a gene therapy company focused on the development of disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details